Open access · CC-BY
via OpenAlex
Synergistic Inhibition of Hepatocellular Carcinoma Growth via Combined mTOR Blockade and Microtubule Disruption
Maria Gonzalez, Javier Ruiz, Lucia Torres, Elena Ruiz
Bulletin of pioneering researches of medical and clinical science · 2025
Abstract
Hepatocellular carcinoma (HCC) poses considerable therapeutic challenges, given that standard chemotherapies offer only restricted benefit. The mammalian target of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition)/sirolimus (mTOR) and microtubules represent two major druggable vulnerabilities in HCC. In this work, we demonstrated that concurrent mTOR inhibition with mTOR inhibitors (everolimus and sirolimus) and the microtubule inhibitor vinorelbine yielded outcomes superior to those of single-agent regimens in HCC PDX models. Our dat
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.51847/3w32mqtxb8
- Canonical
- link ↗
- Fetched
- 2026-10-07 MST
Cite this
APA
Gonzalez, M., Ruiz, J., Torres, L., & Ruiz, E. (2025). Synergistic Inhibition of Hepatocellular Carcinoma Growth via Combined mTOR Blockade and Microtubule Disruption. <em>Bulletin of pioneering researches of medical and clinical science</em>. https://doi.org/10.51847/3w32mqtxb8
Vancouver
Gonzalez M, Ruiz J, Torres L, Ruiz E. Synergistic Inhibition of Hepatocellular Carcinoma Growth via Combined mTOR Blockade and Microtubule Disruption. Bulletin of pioneering researches of medical and clinical science. 2025. doi:10.51847/3w32mqtxb8.
BibTeX
@article{maria2025Synerg,
title = {Synergistic Inhibition of Hepatocellular Carcinoma Growth via Combined mTOR Blockade and Microtubule Disruption},
author = {Maria Gonzalez and Javier Ruiz and Lucia Torres and Elena Ruiz},
journal = {Bulletin of pioneering researches of medical and clinical science},
year = {2025},
doi = {10.51847/3w32mqtxb8},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The Journal of Immunology 2012
Citation only
Inhibition of mTOR promotes dendritic cell activation and survival and enhances therapeutic autologous vaccination in mice (52.4)
BioMed Research International 2015
Open access · CC-BY
Inhibition of mTOR by Rapamycin Results in Auditory Hair Cell Damage and Decreased Spiral Ganglion Neuron Outgrowth and Neurite FormationIn Vitro
The Journal of Immunology 2012
Open access · OA
Inhibition of Mechanistic Target of Rapamycin Promotes Dendritic Cell Activation and Enhances Therapeutic Autologous Vaccination in Mice
Biochemical Society Transactions 2013
Citation only
Adaptation to chronic mTOR inhibition in cancer and in aging
International Journal of Molecular Sciences 2024
Open access · CC-BY
mTOR: Its Critical Role in Metabolic Diseases, Cancer, and the Aging Process
Irina Timofte 2026
Open access · US-GOV